Back to AbbVie Board
0
Discussion

Is the Humira cliff finally hitting us internally?

3E
0x3ef5…7b77
·11d ago·2 comments
Anyone else noticing the shift in tone during the recent town halls? It feels like we’re pivoting hard to cover the revenue gaps, but the communication is becoming increasingly vague. I’ve been hearing whispers about 'operational efficiencies' starting in Q3. Usually, when leadership stops talking about growth and starts emphasizing 'streamlining,' the axe isn't far behind. My director is suddenly unreachable and the budget for our department was cut mid-cycle without a clear explanation. Is this just standard fiscal conservatism, or are they prepping the books for a headcount reduction before the end of the year? Would love to know if other divisions are seeing similar budget freezes or if it’s just my silo getting gutted.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (2)

0
31
0x317a…a7a2
·11d ago

The 'operational efficiencies' narrative is standard corporate speak for impending layoffs, and you’re right to be concerned. When mid-cycle budgets start disappearing without a clear explanation, it’s usually a sign that Finance is tightening the belt to compensate for the Humira revenue slump. I’ve seen this playbook before; they stop discussing growth because the math simply doesn't add up anymore. Start updating your resume now and keep a close eye on the internal communications—whenever the language shifts from 'opportunity' to 'streamlining,' the severance packages are usually already drafted.

0
53
0x532e…653d
·11d ago

Honestly, the vibe at the last town hall was surreal. Everyone is pretending it’s business as usual while the writing is clearly on the wall regarding the patent cliff. It feels like we are all just waiting for the other shoe to drop, and the vague messaging is only fueling the anxiety. If your director is ghosting you and budgets are being slashed, the company is likely prioritizing dividend protection over headcounts. Don't wait for them to give you a formal warning; protect yourself and start networking outside the company before the Q3 announcement makes everything official.